Attached files

file filename
10-K - FORM 10-K - ENTEST BIOMEDICAL, INC.entb0129form10k.htm
EX-32.1 - EXHIBIT 32.1 - ENTEST BIOMEDICAL, INC.entb0129form10kex321.htm
EX-31.2 - EXHIBIT 31.2 - ENTEST BIOMEDICAL, INC.entb0129form10kex312.htm
EX-32.2 - EXHIBIT 32.2 - ENTEST BIOMEDICAL, INC.entb0129form10kex322.htm
EX-31.1 - EXHIBIT 31.1 - ENTEST BIOMEDICAL, INC.entb0129form10kex311.htm
EX-10.37 - EXHIBIT 10.37 - ENTEST BIOMEDICAL, INC.entb0129form10kex1037.htm
EXCEL - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R3.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R8.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R9.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R1.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R4.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R2.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R7.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R6.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R16.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R10.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R30.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R20.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R21.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R42.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R27.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R24.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R17.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R25.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R26.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R43.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R44.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R40.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R22.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R37.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R23.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R35.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R31.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R29.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R14.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R36.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R19.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R41.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R38.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R28.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R13.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R33.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R32.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R15.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R18.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R34.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R39.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R11.htm
EX-10.39 - EXHIBIT 10.39 - ENTEST BIOMEDICAL, INC.entb0129form10kex1039.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R12.htm
v2.4.0.6
Consolidated Statement of Stockholders' Equity (USD $)
Common shares outstanding
Series AA preferred shares outstanding
Series B preferred shares outstanding
Non Voting Convertible Preferred
Additional Paid-in Capital
Contributed Capital
Accumulated Deficit during the Development Stage
Total
Beginning balance, Amount at Aug. 31, 2010 $ 17,553       $ 537,415 $ 15,104 $ (790,814) $ (220,742)
Beginning balance, Shares at Aug. 31, 2010 17,553,040              
Common Shares issued for Cash, Shares 2,217,600              
Common Shares issued for Cash, Amount 2,217       215,383       217,600
Common Shares issued for Debt, Shares 781,712              
Common Shares issued for Debt, Amount 780       340,387       341,167
Common Shares issued to Consultants, Shares 74,383              
Common Shares issued to Consultants, Amount 74       121,967       122,041
Common Stock issued to employees, Shares 163,766              
Common Stock issued to employees, Amount 164       303,235       303,399
Restricted Stock Awards issued to employee, Shares 50,000              
Restricted Stock Awards issued to employee, Amount 50       (50)         
Expense Recognized          10,000       10,000
Discount on Convertible Debt recognized          88,998       88,998
Increases in Contributed capital             259,058    259,058
Preferred Stock issued for Accrued compensation, Shares   5,000            
Preferred Stock issued for Accrued compensation, Amount   5     1,995     2,000
Net Loss for the Year             (951,783) (951,783)
Ending balance, Amount at Aug. 31, 2011 20,838 5     1,619,330 274,162 (1,742,597) 171,738
Ending balance, Shares at Aug. 31, 2011 20,840,501 5,000            
Common Shares issued for Debt, Shares 113,695,700             113,695,700
Common Shares issued for Debt, Amount 113,695       261,264     374,959
Restricted Stock Awards issued to employee, Shares 77,000,000              
Restricted Stock Awards issued to employee, Amount 77,000       (77,000)     0
Common Shares issued for services, Shares 3,272,000             3,272,000
Common Shares issued for services, Amount 3,269       168,481     171,750
Common Shares issued for intangible assets, Shares 2,500,000             2,500,000
Common Shares issued for intangible assets, Amount 2,500       697,500     700,000
Cancellation of Common Shares Issued, Shares (90,000)              
Cancellation of Common Shares Issued, Amount (83)       (86,687)     (86,687)
Restricted Stock Awards to consultant, Shares 15,000,000              
Restricted Stock Awards to consultant, Amount 15,000       (15,000)     0
Expense Recognized         58,491     58,491
Discount on Convertible Debt recognized         350,915     350,915
Series B Preferred Dividend paid, Shares     3,201,397          
Series B Preferred Dividend paid, Amount     3,201   (3,201)     0
Preferred Shares, Shares       75,000       75,000
Preferred Shares, Amount       75,000       75,000
Recognition of Beneficial Conversion Feature         32,142     32,142
Shares issued pursuant to Contractual Obligations, Shares 6,274,726             6,274,726
Shares issued pursuant to Contractual Obligations, Amount 6,274       17,594     23,868
Cancellation of Restricted Stock Award to Employee, Shares (15,000,000)              
Cancellation of Restricted Stock Award to Employee, Shares (15,000)       6,813     (8,187)
Net Loss for the Year             (1,889,563) (1,889,563)
Beneficial Conversion Feature Deemed Dividend             (32,142) (32,142)
Ending balance, Amount at Aug. 31, 2012 $ 223,493 $ 5 $ 3,201 $ 75,000 $ 3,030,642 $ 274,162 $ (3,664,302) $ (57,799)
Ending balance, Shares at Aug. 31, 2012 223,492,927 5,000 3,201,397 75,000